Shanghai, China

Xiaokun Teng

This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Institutes for Biological Sciences, Cas. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaokun Teng. Retrieved from https://idiyas.com/inventor/xiaokun-teng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaokun Teng in Baldness Research

Introduction

Xiaokun Teng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of genetics, particularly in relation to baldness. His work has implications for both diagnosis and treatment, showcasing the intersection of biology and medical innovation.

Latest Patents

Xiaokun Teng holds a patent for a baldness-related gene and the polypeptide encoded thereby. This invention discloses a baldness-related gene and the encoded polypeptide, along with a process for producing the polypeptide through recombinant methods. Additionally, it highlights the use of the Rhor gene and protein in the diagnosis and treatment of baldness. He has 1 patent to his name.

Career Highlights

Teng is affiliated with the Shanghai Institutes for Biological Sciences, a prominent research institution. His work there has focused on advancing our understanding of genetic factors related to hair loss. His research has the potential to lead to new therapeutic approaches for individuals experiencing baldness.

Collaborations

Some of his notable coworkers include Shanru Li and Xiangyin Kong. Their collaborative efforts contribute to the innovative research environment at the Shanghai Institutes for Biological Sciences.

Conclusion

Xiaokun Teng's contributions to baldness research exemplify the vital role of innovation in addressing medical challenges. His patent and ongoing work continue to pave the way for advancements in genetic research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…